Stocks in Play

BELLUS Health Inc.

10:30 AM EST - BELLUS Health Inc. : Announced topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough. BELLUS Health Inc.
shares T.BLU are trading down $12.70 at $3.68.